Cargando…
Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment
Atopic dermatitis (AD) is a chronic autoimmune inflammatory skin disorder which causes a significant clinical problem due to its prevalence. The ongoing treatment for AD is aimed at improving the patient’s quality of life. Additionally, glucocorticoids or immunosuppressants are being used in systemi...
Autores principales: | Garrós, Núria, Bustos-Salgados, Paola, Domènech, Òscar, Rodríguez-Lagunas, María José, Beirampour, Negar, Mohammadi-Meyabadi, Roya, Mallandrich, Mireia, Calpena, Ana C., Colom, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305096/ https://www.ncbi.nlm.nih.gov/pubmed/37375841 http://dx.doi.org/10.3390/ph16060894 |
Ejemplares similares
-
Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome
por: Garrós, Núria, et al.
Publicado: (2022) -
Assessing the Solubility of Baricitinib and Drug Uptake in Different Tissues Using Absorption and Fluorescence Spectroscopies
por: Mohammadi-Meyabadi, Roya, et al.
Publicado: (2022) -
Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model
por: Espinoza, Lupe Carolina, et al.
Publicado: (2020) -
HPV Lesions and Other Issues in the Oral Cavity Treatment and Removal without Pain
por: El Moussaoui, Salima, et al.
Publicado: (2021) -
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022)